Moclobemide clinical trials
How each study uses Moclobemide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Moclobemide
- 3
Studies by the year they started
4 studies that test it; most in 2008 (1)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 4
Jed E. Rose (1) · Beersheva Mental Health Center (1) · China Medical University Hospital (1) · Hannover Medical School (1)
Often tested with
Tested in the same studies.
Amisulpride (2) · Escitalopram (2) · Nicotine Patch (1) · Nicotine (1) · Phenobarbital (1) · Phenytoin (1) · Carbamazepine (1) · Oxcarbazepine (1)
Related medicines
As reviewed, each with the page that says it.
- One of MAO inhibitors (MAOIs) source
Studies
Open first, then newest update. How each study uses Moclobemide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Oral Pre-cancerTerminatedPhase 2China Medical University HospitalNCT03010761Written as Moclobemide
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedPhase 3Hannover Medical SchoolNCT02374567Written as Moclobemide
- Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female SmokersCompletedPhase 2Jed E. RoseNCT01926626Written as Moclobemide
- Benzamide Derivates as Treatment of Clozapine-induced HypersalivationCompletedPhase 3Beersheva Mental Health CenterNCT00534573Written as Amisulpride, Moclobemide
Codes
What other systems call Moclobemide · ClinicalTrials.gg INT008781
- MeSH (NLM) D020912MoclobemideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) PJ0Y7AZB63MOCLOBEMIDEConfirmed FDA, NLM, Wikidata
- RxNorm 30121Confirmed FDA, Wikidata
- Wikidata Q421934moclobemideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C87772MoclobemideOne source FDA
- DrugBank DB01171One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D020912 | Moclobemide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | PJ0Y7AZB63 | MOCLOBEMIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 30121 | — | Confirmed FDA, Wikidata |
| Wikidata | Q421934 | moclobemide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C87772 | Moclobemide | One source FDA |
| DrugBank | DB01171 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.